Analyst Insights

Janney Capital Maintains Neutral On Alexion Despite A Positive Outlook For 2Q14 Results

In a research note published today, Janney Capital analyst Kimberly Lee maintained a Neutral rating on Alexion Pharmaceuticals (ALXN) with a $162 price …

Janney Capital Maintains Buy On Aegerion Ahead Of 2Q14 Earnings Report

In a research report released today, Janney Capital analyst Kimberly Lee maintained a Buy rating on Aegerion Pharmaceuticals (AEGR) with a $90 price target, which …

Cypress: We Remain On The Sidelines Until Any Future Growth Drivers Can Be Addressed, Says Feltl

In a research report released today, Feltl and Company analyst Jeffrey Schreiner reiterated a Hold rating on Cypress Semiconductor (CY) with a $10 price …

Imax: Stock Is Likely To Strengthen As Focus Turns To 2015, Says Canaccord

In a research note released today, Canaccord Genuity analyst Aravinda Galappatthige reaffirmed a Buy rating on Imax Corporation (IMAX) with a price target of $34.50.

We Sensed Growing Momentum In The Field For F5, Says William Blair

In a research note released this morning, William Blair analyst Jason Ader reiterated an Outperform rating on F5 Networks (FFIV) ahead of the upcoming third-quarter results. …

PriceSmart: Long-Term View Unchanged Despite Weak Sales Trends, Says Roth Capital

In a research note published Friday, Roth Capital analyst Dave King reiterated a Buy rating on PriceSmart Inc. (PSMT) with a price target of …

Infosys: We Recommend Investors Remain On The Sidelines, Says William Blair

In a research report released Friday, William Blair analyst Anil Doradla maintained a Market Perform rating on Infosys Technologies (INFY), despite Q1 earnings that …

Wedbush Reiterated Outperform On H&R Block Following Meetings With Management

In a research note issued Friday, Wedbush analyst Gil Luria reiterated an Outperform rating on H&R Block (HRB) with a $37 price target, which represents …

Google: Wedbush Sees Upside Potential In 2Q14, But Keeps Neutral Stance

In a research note released Friday, Wedbush analyst Shyam Patil maintained a Neutral rating on Google (GOOG) with a price target of $600, …

Maxim Reaffirms Buy On Gilead Sciences Following Sovaldi Pricing Details Request

In a research report released Friday, Maxim Group analyst Jason Kolbert reaffirmed a Buy rating on Gilead Sciences (GILD) with a price target …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts